IGM Biosciences, Inc. ( IGMS) - Key Metrics
Stock symbol IGMS is outdated, potentially delisted? Maybe it is available on other exchange?
IGMS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q2 | $2.34 | $1.59 | -$0.83 | -$0.83 |
| 2025Q1 | $0.01 | -$0.86 | -$0.53 | -$0.53 |
| 2024Q4 | $0.01 | -$0.61 | -$0.58 | -$0.59 |
| 2024Q3 | $0.01 | -$1.01 | -$0.63 | -$0.65 |
| 2024Q2 | $0.02 | -$0.79 | -$0.62 | -$0.64 |
IGMS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q2 | ? | 0.18 |
| 2025Q1 | ? | -0.33 |
| 2024Q4 | ? | -2.52 |
| 2024Q3 | ? | -4.08 |
| 2024Q2 | ? | -2.14 |
IGMS
Price: $1.27
52 week price:
Earnings Per Share: -0.90 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 224815
Market Capitalization: 76.6 million